MARK HERMAN to Humans
This is a "connection" page, showing publications MARK HERMAN has written about Humans.
Connection Strength
0.324
-
Advancing de novo lipogenesis: Genetic and metabolic insights. Cell Metab. 2025 Jan 07; 37(1):3-4.
Score: 0.026
-
HGFAC is a ChREBP-regulated hepatokine that enhances glucose and lipid homeostasis. JCI Insight. 2023 01 10; 8(1).
Score: 0.023
-
Molecular aspects of fructose metabolism and metabolic disease. Cell Metab. 2021 12 07; 33(12):2329-2354.
Score: 0.021
-
Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets. J Biol Chem. 2021 Jan-Jun; 296:100623.
Score: 0.020
-
Metabolic liver disease - what's in a name? Nat Rev Endocrinol. 2021 02; 17(2):79-80.
Score: 0.020
-
One small step for mice, one giant leap for GWAS? J Clin Invest. 2019 10 01; 129(10):4083-4085.
Score: 0.018
-
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes. Curr Diab Rep. 2019 08 03; 19(9):77.
Score: 0.018
-
Fructose metabolism and metabolic disease. J Clin Invest. 2018 02 01; 128(2):545-555.
Score: 0.016
-
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Mol Metab. 2017 01; 6(1):14-21.
Score: 0.015
-
ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest. 2016 11 01; 126(11):4372-4386.
Score: 0.015
-
The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis. Trends Endocrinol Metab. 2016 10; 27(10):719-730.
Score: 0.014
-
Making Biological Sense of GWAS Data: Lessons from the FTO Locus. Cell Metab. 2015 Oct 06; 22(4):538-9.
Score: 0.014
-
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature. 2012 Apr 19; 484(7394):333-8.
Score: 0.011
-
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest. 2006 Jul; 116(7):1767-75.
Score: 0.007
-
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development. Diabetologia. 2025 May; 68(5):930-939.
Score: 0.007
-
Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults. J Nutr. 2022 11; 152(11):2534-2545.
Score: 0.006
-
Maladaptive positive feedback production of ChREBP? underlies glucotoxic ?-cell failure. Nat Commun. 2022 07 30; 13(1):4423.
Score: 0.006
-
Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations. Circ Genom Precis Med. 2021 08; 14(4):e003288.
Score: 0.005
-
Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol Metab. 2021 10; 52:101261.
Score: 0.005
-
Beverage Consumption and Longitudinal Changes in Lipoprotein Concentrations and Incident Dyslipidemia in US Adults: The Framingham Heart Study. J Am Heart Assoc. 2020 03 03; 9(5):e014083.
Score: 0.005
-
Sleeve gastrectomy rapidly enhances islet function independently of body weight. JCI Insight. 2019 03 21; 4(6).
Score: 0.004
-
The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. Cell Metab. 2018 Jun 05; 27(6):1281-1293.e7.
Score: 0.004
-
Activation of Nrf2 Is Required for Normal and ChREBPa-Augmented Glucose-Stimulated ?-Cell Proliferation. Diabetes. 2018 08; 67(8):1561-1575.
Score: 0.004
-
Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease. J Clin Gastroenterol. 2018 May/Jun; 52(5):444-451.
Score: 0.004
-
Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis. Cell Metab. 2018 Jun 05; 27(6):1249-1262.e4.
Score: 0.004
-
Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes. Diabetes. 2018 07; 67(7):1428-1440.
Score: 0.004
-
Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis. Diabetologia. 2018 02; 61(2):317-330.
Score: 0.004
-
The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans. Mol Metab. 2017 11; 6(11):1493-1502.
Score: 0.004
-
Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. Liver Int. 2016 08; 36(8):1213-20.
Score: 0.004
-
Induction of the ChREBP? Isoform Is Essential for Glucose-Stimulated ?-Cell Proliferation. Diabetes. 2015 Dec; 64(12):4158-70.
Score: 0.003
-
Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans. J Clin Endocrinol Metab. 2015 May; 100(5):E688-96.
Score: 0.003
-
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014 Oct 09; 159(2):318-32.
Score: 0.003
-
Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients. Clin Endocrinol (Oxf). 2012 Jul; 77(1):56-61.
Score: 0.003
-
CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep. 2011 Sep 30; 12(10):1069-76.
Score: 0.003
-
Leveraging leptin for type I diabetes? Proc Natl Acad Sci U S A. 2010 Mar 16; 107(11):4793-4.
Score: 0.002